This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Tuberculosis


  • Nurse Researchers Toil to Curb Spread of Infectious Disease
    Fighting infectious disease, the very heart of public health and the genesis of contemporary nursing, is about more than handwashing and immunizations. It’s about screening and early detection, identifying risk and protective factors, and educating clinicians, ...More
    June 12, 2009 Posted in News
  • Best Ways to Use Standard TB Vaccine
    In a study funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, Saint Louis University’s Center for Vaccine Development is investigating whether the standard vaccine used in foreign countries against ...More
    June 12, 2009 Posted in News
  • Results from Trial of MDR-TB Drug are Encouraging
    Interim results from an ongoing phase 2, randomized, placebo-controlled trial of the investigational drug TMC207 for the treatment of multidrug-resistant tuberculosis (MDR-TB) were published in the New England Journal of Medicine today. TMC207 is being developed by Tibotec ...More
    June 3, 2009 Posted in News
  • TB: Hiding in Plain Sight
    Current research suggests that Mycobacterium tuberculosis can evade the immune response. The paper by Rahman et al., "Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory T cells in the ...More
    May 26, 2009 Posted in News, Hand Hygiene, PPE & Standard Precautions
  • U.S. Should Bolster Funding to Improve Public Health
    To fulfill America's humanitarian obligations as a member of the international community and to invest in the nation's long-term health, economic interests, and national security, the United States should reaffirm and increase its commitment to improving the health of ...More
    May 20, 2009 Posted in News
  • Study Suggests TB Screening Needs to be Targeted for Maximum Public Health Benefit
    New estimates of the likelihood that a latent case of tuberculosis (TB) will become active have resulted in a roughly 50 percent increase over previous estimates of the number of people needed to be screened (NNS) to prevent an active infection, limiting the cost ...More
    May 20, 2009 Posted in News
  • Bacteria With a Built-In Thermometer
    Researchers in the Molecular Infection Biology group at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Braunschweig Technical University could now demonstrate for the first time that bacteria of the Yersinia genus possess a unique protein ...More
    May 20, 2009 Posted in News
  • What Happened to the TB Vaccine?
    A team of VanderbiltUniversityMedicalCenter investigators has cracked one of clinical medicine's enduring mysteries – what happened to the tuberculosis vaccine. The once-effective vaccine no longer prevents the bacterial lung infection that kills more than 1.7 million ...More
    May 19, 2009 Posted in News
  • Infection Control Needed to Curb Spread of XDR-TB Among Healthcare Workers
    Healthcare workers in South Africa are at a significantly increased risk of developing extensively drug-resistant tuberculosis (XDR-TB) in a trend which threatens to further exacerbate the already beleaguered healthcare systems in sub-Saharan countries, according to results ...More
    May 18, 2009 Posted in News
  • NIH Grants Will Strengthen Fight Against HIV/AIDS-Tuberculosis
    The Fogarty International Center of the National Institutes of Health today announced it will award $11.75 million over five years in grants to institutions to strengthen the fight against HIV/AIDS and tuberculosis in Haiti, Uganda and China and establish a new program in ...More
    April 16, 2009 Posted in News